Maureen Callaghan

1.0k total citations · 1 hit paper
15 papers, 729 citations indexed

About

Maureen Callaghan is a scholar working on Physiology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maureen Callaghan has authored 15 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Neurology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maureen Callaghan's work include Neurological Disorders and Treatments (4 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Diet and metabolism studies (3 papers). Maureen Callaghan is often cited by papers focused on Neurological Disorders and Treatments (4 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Diet and metabolism studies (3 papers). Maureen Callaghan collaborates with scholars based in United States and New Zealand. Maureen Callaghan's co-authors include Suzanne Craft, Laura D. Baker, Angela J. Hanson, Brenna Cholerton, Emily H. Trittschuh, Amy Claxton, Matthew Arbuckle, A. Morgan, Christian Behl and James B. Leverenz and has published in prestigious journals such as Nature, Pain and Journal of Alzheimer s Disease.

In The Last Decade

Maureen Callaghan

15 papers receiving 711 citations

Hit Papers

Long-Acting Intranasal Insulin Detemir Improves Cognition... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Callaghan United States 9 433 144 137 114 114 15 729
Matthew Arbuckle United States 6 370 0.9× 125 0.9× 143 1.0× 176 1.5× 59 0.5× 8 643
Ikki Ishida Japan 17 344 0.8× 224 1.6× 59 0.4× 112 1.0× 177 1.6× 39 977
Stanley I. Rapoport United States 8 468 1.1× 247 1.7× 124 0.9× 63 0.6× 174 1.5× 11 811
Masakazu Kubota Japan 13 341 0.8× 198 1.4× 97 0.7× 55 0.5× 41 0.4× 30 679
Isabel Arrieta‐Cruz Mexico 19 350 0.8× 344 2.4× 71 0.5× 90 0.8× 45 0.4× 42 978
Katarzyna Głombik Poland 21 205 0.5× 320 2.2× 271 2.0× 124 1.1× 58 0.5× 42 1.2k
Phillipe D. O’Brien United States 17 654 1.5× 366 2.5× 165 1.2× 157 1.4× 35 0.3× 22 1.3k
Hsing-Cheng Liu Taiwan 15 313 0.7× 217 1.5× 83 0.6× 34 0.3× 199 1.7× 23 920
Lindsay Joy Spielman Canada 8 250 0.6× 238 1.7× 161 1.2× 77 0.7× 55 0.5× 9 696
Matilde Otero‐Losada Argentina 17 148 0.3× 226 1.6× 127 0.9× 71 0.6× 59 0.5× 65 942

Countries citing papers authored by Maureen Callaghan

Since Specialization
Citations

This map shows the geographic impact of Maureen Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Callaghan more than expected).

Fields of papers citing papers by Maureen Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Callaghan. The network helps show where Maureen Callaghan may publish in the future.

Co-authorship network of co-authors of Maureen Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Callaghan. A scholar is included among the top collaborators of Maureen Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Callaghan. Maureen Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zydenbos, S. M., et al.. (2016). Effect of <i>Serratia entomophila</i> and diazinon applied with seed against grass grub populations on the North Island volcanic plateau. Proceedings of the New Zealand Weed Control Conference. 69. 86–93. 9 indexed citations
2.
Callaghan, Maureen, M. J. Wilson, & S. M. Zydenbos. (2015). Biopesticides for New Zealands pests opportunities and challenges. Proceedings of the New Zealand Weed Control Conference. 68. 443–443. 2 indexed citations
3.
Baker, Laura D., Jeannine S. Skinner, Suzanne Craft, et al.. (2015). O5‐04‐05: Aerobic exercise reduces phosphorylated tau protein in cerebrospinal fluid in older adults with mild cognitive impairment. Alzheimer s & Dementia. 11(7S_Part_7). 6 indexed citations
4.
Claxton, Amy, Laura D. Baker, Angela J. Hanson, et al.. (2015). Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia. Journal of Alzheimer s Disease. 44(3). 897–906. 370 indexed citations breakdown →
5.
Huprikar, Nikhil, et al.. (2013). Agranulocytosis with deferiprone treatment of superficial siderosis. BMJ Case Reports. 2013. bcr2013010099–bcr2013010099. 14 indexed citations
6.
Hanson, Angela J., Pattie S. Green, Thomas J. Montine, et al.. (2013). Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides. JAMA Neurology. 70(8). 972–972. 81 indexed citations
7.
Claxton, Amy, Laura D. Baker, Angela J. Hanson, et al.. (2013). P3–276: Long‐acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early‐stage Alzheimer's dementia. Alzheimer s & Dementia. 9(4S_Part_16). 2 indexed citations
8.
Craft, Suzanne, Amy Claxton, Laura D. Baker, et al.. (2013). O1–06–06: Therapeutic effects of long‐acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment. Alzheimer s & Dementia. 9(4S_Part_3). 6 indexed citations
9.
Claxton, Amy, Charles W. Wilkinson, Laura D. Baker, et al.. (2012). P3‐358: Intranasal insulin treatment response in Alzheimer's disease influenced by glucose‐stimulated insulin secretion. Alzheimer s & Dementia. 8(4S_Part_16). 2 indexed citations
10.
Baker, Laura D., Jeannine S. Skinner, Thomas J. Montine, et al.. (2012). High-Intensity Physical Activity Modulates Diet Effects on Cerebrospinal Amyloid-β Levels in Normal Aging and Mild Cognitive Impairment. Journal of Alzheimer s Disease. 28(1). 137–146. 40 indexed citations
11.
Green, Pattie S., Thomas J. Montine, Laura D. Baker, et al.. (2011). Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment. Archives of Neurology. 68(6). 743–52. 121 indexed citations
12.
Craft, Suzanne, Laura D. Baker, Pattie S. Green, et al.. (2010). P3‐455: A randomized, placebo‐controlled trial of intranasal insulin in amnestic MCI and early Alzheimer's. Alzheimer s & Dementia. 6(4S_Part_19). 7 indexed citations
13.
Young, Sandra, R.J. Townsend, & Maureen Callaghan. (2009). Bacterial entomopathogens improve cereal establishment in the presence of grass grub larvae. Proceedings of the New Zealand Weed Control Conference. 62. 1–6. 8 indexed citations
14.
Callaghan, Maureen, et al.. (1978). Changes in somatic sensitivity during transcutaneous electrical analgesia. Pain. 5(2). 115–127. 20 indexed citations
15.
Segal, David S., Maureen Callaghan, & Arnold J. Mandell. (1975). Alterations in behaviour and catecholamine biosynthesis induced by lithium. Nature. 254(5495). 58–59. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026